(Q35788055)

10 August 2017

1 reference

title

Long-acting beta 2-adrenoceptor agonists and exercise-induced asthma: lessons to guide us in the future (English)

1 reference

10 August 2017

1 reference

1 reference

Sandra D Anderson

1

0 references

author name string

John D Brannan

series ordinal

2

1 reference

10 August 2017

publication date

1 January 2004

1 reference

10 August 2017

1 reference

10 August 2017

volume

6

1 reference

10 August 2017

issue

3

1 reference

10 August 2017

page(s)

161-175

1 reference

https://scigraph.springernature.com/pub.10.2165/00148581-200406030-00003

10 August 2017

exact match

0 references

cites work

Beta2-adrenoceptor polymorphism and bronchoprotective sensitivity with regular short- and long-acting beta2-agonist therapy

1 reference

12 December 2020

The new phosphodiesterase 4 inhibitor roflumilast is efficacious in exercise-induced asthma and leads to suppression of LPS-stimulated TNF-alpha ex vivo

1 reference

12 December 2020

Airway subsensitivity with long-acting beta 2-agonists. Is there cause for concern?

1 reference

12 December 2020

Tolerance to beta-agonists during acute bronchoconstriction

1 reference

12 December 2020

Effects of terbutaline and budesonide on sputum cells and bronchial hyperresponsiveness in asthma

1 reference

12 December 2020

The refractory period after exercise-induced asthma: its duration and relation to the severity of exercise

1 reference

12 December 2020

The arginine-16 beta2-adrenoceptor polymorphism predisposes to bronchoprotective subsensitivity in patients treated with formoterol and salmeterol

1 reference

12 December 2020

Serious asthma exacerbations in asthmatics treated with high-dose formoterol

1 reference

12 December 2020

Acute anti-inflammatory effects of inhaled budesonide in asthma: a randomized controlled trial.

1 reference

12 December 2020

Bronchodilator tolerance: the impact of increasing bronchoconstriction.

1 reference

12 December 2020

Tolerance to the nonbronchodilator effects of inhaled beta 2-agonists in asthma

1 reference

12 December 2020

Should combination therapy with inhaled corticosteroids and long-acting beta2-agonists be prescribed as initial maintenance treatment for asthma?

1 reference

12 December 2020

Association between β2-adrenoceptor polymorphism and susceptibility to bronchodilator desensitisation in moderately severe stable asthmatics

1 reference

12 December 2020

One year treatment with salmeterol compared with beclomethasone in children with asthma. The Dutch Paediatric Asthma Study Group

1 reference

12 December 2020

An evaluation of oral hexoprenaline sulphate (Ipradol) in exercise-induced asthma

1 reference

12 December 2020

Protective effect and duration of action of formoterol aerosol on exercise-induced asthma

1 reference

12 December 2020

Airway responses to hyperventilation of cold dry air: duration of protection by cromolyn sodium

1 reference

12 December 2020

Human airway ion transport. Part one.

1 reference

12 December 2020

Protection against cold air and exercise-induced bronchoconstriction while on regular treatment with Oxis

1 reference

12 December 2020

Suppression of exercise-induced asthma by salbutamol, theophylline, atropine, cromolyn, and placebo in a group of asthmatic children

1 reference

12 December 2020

The airway microvasculature and exercise induced asthma

1 reference

12 December 2020

Effects of enprofylline and theophylline on exercise-induced asthma

1 reference

12 December 2020

Effect of polymorphism of the beta(2)-adrenergic receptor on response to regular use of albuterol in asthma

1 reference

12 December 2020

Long-acting beta(2)-agonists in management of childhood asthma: A critical review of the literature

1 reference

12 December 2020

A randomized, double-blind, single-dose, crossover clinical trial of the onset and duration of protection from exercise-induced bronchoconstriction by formoterol and albuterol

1 reference

12 December 2020

Effects of single-dose fluticasone on exercise-induced asthma in asthmatic children: a pilot study

1 reference

12 December 2020

The Influence of Polymorphism at Position 16 of the β2-Adrenoceptor on the Development of Tolerance to β-Agonist

1 reference

12 December 2020

An evaluation of pharmacotherapy for exercise-induced asthma

1 reference

12 December 2020

Clinical exercise testing with reference to lung diseases: indications, standardization and interpretation strategies

1 reference

12 December 2020

The effect of regular inhaled albuterol on exercise-induced bronchoconstriction

1 reference

12 December 2020

Salmeterol in exercise-induced bronchoconstriction in asthmatic children: comparison of two doses

1 reference

12 December 2020

Formoterol thrice weekly does not result in the development of tolerance to bronchoprotection

1 reference

12 December 2020

Role of leukotrienes in bronchial hyperresponsiveness and cellular responses in airways

1 reference

12 December 2020

Bronchoprotection by salmeterol: cell stabilization or functional antagonism? Comparative effects on histamine- and AMP-induced bronchoconstriction

1 reference

12 December 2020

Mast cell tryptase release and asthmatic responses to allergen increase with regular use of salbutamol

1 reference

12 December 2020

Allergy and asthma in elite summer sport athletes

1 reference

12 December 2020

Reversing acute bronchoconstriction in asthma: the effect of bronchodilator tolerance after treatment with formoterol.

1 reference

12 December 2020

Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group

1 reference

12 December 2020

Tolerance to the protective effect of salmeterol on allergen challenge

1 reference

12 December 2020

Flow-dependent effect of formoterol dry-powder inhaled from the Aerolizerfi

1 reference

12 December 2020

Plasma cyclic AMP levels in response to exercise and terbutaline sulphate aerosol in normal and asthmatic subjects

1 reference

12 December 2020

Increased bronchial responsiveness to exercise and histamine after allergen challenge in children with asthma

1 reference

12 December 2020

Salbutamol up-regulates PDE4 activity and induces a heterologous desensitization of U937 cells to prostaglandin E2. Implications for the therapeutic use of beta-adrenoceptor agonists

1 reference

12 December 2020

Protective effect and duration of action of inhaled formoterol and salbutamol on exercise-induced asthma in children

1 reference

12 December 2020

Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999

1 reference

12 December 2020

Dose duration of nebulized nedocromil sodium in exercise-induced asthma

1 reference

12 December 2020

Increased urinary excretion of LTE4 after exercise and attenuation of exercise-induced bronchospasm by montelukast, a cysteinyl leukotriene receptor antagonist

1 reference

12 December 2020

Duration of protective effect of terbutaline sulfate and cromolyn sodium alone and in combination on exercise-induced asthma

1 reference

12 December 2020

Prevention of exercise-induced bronchospasm in pediatric asthma patients: a comparison of salmeterol powder with albuterol

1 reference

12 December 2020

A Comparison of Oral Theophylline and Oral Salbutamol in Exercise-Induced Asthma

1 reference

12 December 2020

Mannitol as a challenge test to identify exercise-induced bronchoconstriction in elite athletes

1 reference

12 December 2020

Salmeterol (Serevent) asthma trial halted early

1 reference

12 December 2020

Beta-adrenergic receptors and their regulation.

1 reference

12 December 2020

Indirect bronchial hyperresponsiveness in asthma: mechanisms, pharmacology and implications for clinical research

1 reference

12 December 2020

Effect of inhalation of corticosteroids on exercise induced asthma: randomised double blind crossover study of budesonide in asthmatic children

1 reference

12 December 2020

Albuterol-induced downregulation of Gsalpha accounts for pulmonary beta(2)-adrenoceptor desensitization in vivo

1 reference

12 December 2020

Desensitization of beta2-adrenoceptor-mediated responses by short-acting beta2-adrenoceptor agonists in human lung mast cells.

1 reference

12 December 2020

A high dose of albuterol does not overcome bronchoprotective subsensitivity in asthmatic subjects receiving regular salmeterol or formoterol

1 reference

12 December 2020

The effect of indomethacin on exercise-induced bronchoconstriction and refractoriness after exercise

1 reference

12 December 2020

The use of the treadmill for assessing exercise-induced asthma and the effect of varying the severity and duration of exercise

1 reference

12 December 2020

The duration of action of the combination of fenoterol hydrobromide and ipratropium bromide in protecting against asthma provoked by hyperpnea

1 reference

12 December 2020

Arterial plasma histamine levels at rest, and during and after exercise in patients with asthma: effects of terbutaline aerosol

1 reference

12 December 2020

Comparison of the protective effect of formoterol and of salmeterol against exercise-induced bronchospasm when given immediately before a cycloergometric test

1 reference

12 December 2020

Beta2-agonist tolerance and exercise-induced bronchospasm

1 reference

12 December 2020

Metabolic and ventilatory changes in asthmatic patients during and after exercise.

1 reference

12 December 2020

Occurrence of exercise induced bronchospasm in elite runners: dependence on atopy and exposure to cold air and pollen

1 reference

12 December 2020

Desensitisation of mast cell beta2-adrenoceptor-mediated responses by salmeterol and formoterol.

1 reference

12 December 2020

Changes in Lung Volumes and Airway Resistance After Exercise in Asthmatic Subjects1–3

1 reference

12 December 2020

Interaction between glucocorticoids and beta2 agonists on bronchial airway smooth muscle cells through synchronised cellular signalling

1 reference

12 December 2020

Effects of inhaled budesonide alone and in combination with low-dose terbutaline in children with exercise-induced asthma

1 reference

12 December 2020

Decreased bronchodilating effect of salbutamol in relieving methacholine induced moderate to severe bronchoconstriction during high dose treatment with long acting beta2 agonists

1 reference

12 December 2020

Clinical effect of Diskus ™ dry-powder inhaler at low and high inspiratory flow-rates in asthmatic children

1 reference

12 December 2020

Acute protection against exercise-induced bronchoconstriction by formoterol, salmeterol and terbutaline

1 reference

12 December 2020

Indirect airway challenges

1 reference

12 December 2020

Oral montelukast compared with inhaled salmeterol to prevent exercise-induced bronchoconstriction. A randomized, double-blind trial. Exercise Study Group

1 reference

12 December 2020

Exercise induced asthma: response to disodium cromoglycate in skin-test positive and skin-test negative subjects

1 reference

12 December 2020

THE PLACE OF PHYSICAL EXERCISE AND BRONCHODILATOR DRUGS IN THE ASSESSMENT OF THE ASTHMATIC CHILD.

1 reference

12 December 2020

Lack of protective effect of high-dose ipratropium on bronchoconstriction following exercise with cold air breathing in patients with mild asthma

1 reference

12 December 2020

Tachyphylaxis following regular use of formoterol in exercise-induced bronchospasm

1 reference

12 December 2020

Reduced protection against exercise induced bronchoconstriction after chronic dosing with salmeterol

1 reference

12 December 2020

Formoterol via Turbuhaler gave better protection than terbutaline against repeated exercise challenge for up to 12 hours in children and adolescents

1 reference

12 December 2020

Scientific rationale for inhaled combination therapy with long-acting beta2-agonists and corticosteroids

1 reference

12 December 2020

Sodium cromoglycate as a pressurised aerosol (vicrom) in exercise-induced asthma

1 reference

12 December 2020

Laboratory protocol for exercise asthma to evaluate salbutamol given by two devices

1 reference

12 December 2020

The effects of indomethacin on refractoriness following exercise both with and without a bronchoconstrictor response

1 reference

12 December 2020

Heterogeneity in beta-adrenergic receptor kinase expression in the lung accounts for cell-specific desensitization of the beta2-adrenergic receptor

1 reference

12 December 2020

Human mast cell and airway smooth muscle cell interactions: implications for asthma.

1 reference

12 December 2020

Distribution and degranulation of airway mast cells in normal and asthmatic subjects

1 reference

12 December 2020

A comparison of salmeterol and formoterol in attenuating airway responses to short-acting β2-agonists

1 reference

12 December 2020

Inhaled formoterol in the prevention of exercise-induced bronchoconstriction in asthmatic children

1 reference

12 December 2020

Mast-cell infiltration of airway smooth muscle in asthma.

1 reference

12 December 2020

Montelukast versus salmeterol in patients with asthma and exercise-induced bronchoconstriction. Montelukast/Salmeterol Exercise Study Group

1 reference

12 December 2020

Evidence for mast cell activation during exercise-induced bronchoconstriction

1 reference

12 December 2020

Self-reported symptoms and exercise-induced asthma in the elite athlete

1 reference

12 December 2020

Beta-agonists and asthma: too much of a good thing?

1 reference

12 December 2020

Exercise in elite summer athletes: Challenges for diagnosis

1 reference

12 December 2020

One-year efficacy and safety of inhaled formoterol dry powder in children with persistent asthma

1 reference

12 December 2020

Exercise-induced asthma in figure skaters

1 reference

12 December 2020

Long-term circadian effects of salmeterol in asthmatic children treated with inhaled corticosteroids

1 reference

12 December 2020

The effect of zafirlukast on repetitive exercise-induced bronchoconstriction: the possible role of leukotrienes in exercise-induced refractoriness

1 reference

12 December 2020

Exercise-induced asthma in children: a marker of airway inflammation.

1 reference

12 December 2020

Dose-responses over time to inhaled fluticasone propionate treatment of exercise- and methacholine-induced bronchoconstriction in children with asthma

1 reference

12 December 2020

Is there a unifying hypothesis for exercise-induced asthma?

1 reference

12 December 2020

Inhibition of exercise-induced asthma by different pharmacological pathways

1 reference

12 December 2020

The mechanism of exercise-induced asthma is ...

1 reference

12 December 2020

In vivo quantification of human pulmonary beta-adrenoceptors: effect of beta-agonist therapy

1 reference

12 December 2020

Effects of formoterol and budesonide on GM-CSF and IL-8 secretion by triggered human bronchial epithelial cells

1 reference

12 December 2020

Effect of long‐acting β2 agonists on exacerbation rates of asthma in children

1 reference

12 December 2020

Time course of effect of disodium cromoglycate on exercise-induced asthma

1 reference

12 December 2020

The beta-adrenoceptor

1 reference

12 December 2020

Salmeterol provides prolonged protection against exercise-induced bronchoconstriction in a majority of subjects with mild, stable asthma

1 reference

12 December 2020

Low-dose budesonide improves exercise-induced bronchospasm in schoolchildren

1 reference

12 December 2020

Effect of regular inhaled salbutamol on airway responsiveness and airway inflammation in rhinitic non-asthmatic subjects

1 reference

12 December 2020

Effect of long-term salmeterol treatment on exercise-induced asthma

1 reference

12 December 2020

Effect of inhaled budesonide on lung function and airway inflammation. Assessment by various inflammatory markers in mild asthma

1 reference

12 December 2020

Exercise-induced refractoriness in asthmatic subjects involves leukotriene and prostaglandin interdependent mechanisms

1 reference

12 December 2020

Severity of exercise-induced bronchoconstriction is related to airway eosinophilic inflammation in patients with asthma.

1 reference

12 December 2020

Prevention of exercise induced asthma by inhaled salmeterol xinafoate

1 reference

12 December 2020

The protective effect and duration of action of metaproterenol aerosol on exercise-induced asthma

1 reference

12 December 2020

Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling

1 reference

12 December 2020

Low-dose inhaled budesonide once or twice daily for 27 months in children with mild asthma

1 reference

12 December 2020

Comparison of combination inhalers vs inhaled corticosteroids alone in moderate persistent asthma.

1 reference

12 December 2020

Mast cell numbers are increased in the smooth muscle of human sensitized isolated bronchi

1 reference

12 December 2020

Mast cell tryptase potentiates histamine-induced contraction in human sensitized bronchus

1 reference

12 December 2020

Inhaled corticosteroids do not prevent the development of tolerance to the bronchoprotective effect of salmeterol

1 reference

12 December 2020

Chronic systemic administration of salmeterol to rats promotes pulmonary beta(2)-adrenoceptor desensitization and down-regulation of G(s alpha)

1 reference

12 December 2020

Inhaled and oral salbutamol in exercise-induced asthma

1 reference

12 December 2020

Overnight protection by inhaled salmeterol on exercise-induced asthma in children

1 reference

12 December 2020

Prevalence of respiratory symptoms in an athlete population.

1 reference

12 December 2020

Duration of action of formoterol and salbutamol dry-powder inhalation in prevention of exercise-induced asthma in children

1 reference

12 December 2020

Use of serial exercise tests to assess the efficacy and duration of action of drugs for asthma

1 reference

12 December 2020

Formoterol provides long-lasting protection against exercise-induced bronchospasm

1 reference

12 December 2020

Responses to bronchial challenge submitted for approval to use inhaled beta2-agonists before an event at the 2002 Winter Olympics

1 reference

12 December 2020

Duration of Protection by Inhaled Salmeterol in Exercise-induced Asthma

1 reference

12 December 2020

Phosphodiesterase 4 and tolerance to beta 2-adrenoceptor agonists in asthma

1 reference

12 December 2020

Tolerance to the protective effects of salmeterol on methacholine-induced bronchoconstriction: influence of inhaled corticosteroids

1 reference

12 December 2020

Salmeterol tachyphylaxis in steroid treated asthmatic subjects

1 reference

12 December 2020

Tolerance to the bronchoprotective effect of salmeterol in adolescents with exercise-induced asthma using concurrent inhaled glucocorticoid treatment.

1 reference

12 December 2020

Exercise-induced asthma

1 reference

12 December 2020

Multiple exercise and histamine challenge in asthmatic patients

1 reference

12 December 2020

Evidence of mast cell activation and leukotriene release after mannitol inhalation

1 reference

12 December 2020

Comparison of oral and inhaled metaproterenol for prevention of exercise‐induced asthma

1 reference

12 December 2020

Prolonged recovery from exercise-induced asthma with increasing age in childhood

1 reference

12 December 2020

Exercise-induced asthma: a difference in opinion regarding the stimulus

1 reference

12 December 2020

Mucociliary clearance during and after isocapnic hyperventilation with dry air in the presence of frusemide

1 reference

12 December 2020

Inhaled and oral bronchodilator therapy in exercise induced asthma

1 reference

12 December 2020

10.2165/00148581-200406030-00003

Identifiers

DOI

1 reference

Dimensions Publication ID

10 August 2017

1049608949

0 references

1 reference